These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18705902)

  • 1. The Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART): an adaptive design phase I dose-escalation study of high-dose lovastatin in acute ischemic stroke.
    Elkind MS; Sacco RL; MacArthur RB; Fink DJ; Peerschke E; Andrews H; Neils G; Stillman J; Corporan T; Leifer D; Cheung K
    Int J Stroke; 2008 Aug; 3(3):210-8. PubMed ID: 18705902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose lovastatin for acute ischemic stroke: results of the phase I dose escalation neuroprotection with statin therapy for acute recovery trial (NeuSTART).
    Elkind MS; Sacco RL; Macarthur RB; Peerschke E; Neils G; Andrews H; Stillman J; Corporan T; Leifer D; Liu R; Cheung K
    Cerebrovasc Dis; 2009; 28(3):266-75. PubMed ID: 19609078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice.
    Amin-Hanjani S; Stagliano NE; Yamada M; Huang PL; Liao JK; Moskowitz MA
    Stroke; 2001 Apr; 32(4):980-6. PubMed ID: 11283400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin Therapy in Ischemic Stroke Models: A Meta-Analysis.
    Christophe B; Karatela M; Sanchez J; Pucci J; Connolly ES
    Transl Stroke Res; 2020 Aug; 11(4):590-600. PubMed ID: 31788761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medium-intensity statin with ezetimibe versus high-intensity statin in acute ischemic cerebrovascular disease (MESIA): A randomized clinical trial.
    Lv X; Liu X; Peng Y; Li W; Wang J; Chen X; Lei J; Tang C; Luo S; Mai W; Cai Y; Fan Q; Liu C; Zhang L
    J Stroke Cerebrovasc Dis; 2024 May; 33(5):107647. PubMed ID: 38431112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized Controlled Trial of Early Versus Delayed Statin Therapy in Patients With Acute Ischemic Stroke: ASSORT Trial (Administration of Statin on Acute Ischemic Stroke Patient).
    Yoshimura S; Uchida K; Daimon T; Takashima R; Kimura K; Morimoto T;
    Stroke; 2017 Nov; 48(11):3057-3063. PubMed ID: 29030478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and clinical relevance of drug interactions with lovastatin and simvastatin: an observational database study.
    Tirkkonen T; Ryynänen A; Vahlberg T; Irjala K; Klaukka T; Huupponen R; Laine K
    Drug Saf; 2008; 31(3):231-40. PubMed ID: 18302447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exenatide effects on statin pharmacokinetics and lipid response.
    Kothare PA; Linnebjerg H; Skrivanek Z; Reddy S; Mace K; Pena A; Han J; Fineman M; Mitchell M
    Int J Clin Pharmacol Ther; 2007 Feb; 45(2):114-20. PubMed ID: 17323791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lovastatin for adult patients with dengue: protocol for a randomised controlled trial.
    Whitehorn J; Van Vinh Chau N; Truong NT; Tai LT; Van Hao N; Hien TT; Wolbers M; Merson L; Dung NT; Peeling R; Simmons C; Wills B; Farrar J
    Trials; 2012 Oct; 13():203. PubMed ID: 23114081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term high-dose effect of lovastatin on thrombolysis by rt-PA in a human whole-blood in vitro clot model.
    Kandadai MA; Meunier J; Lindsell CJ; Shaw GJ; Elkind MS
    Curr Neurovasc Res; 2012 Aug; 9(3):207-13. PubMed ID: 22621227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity of the HMG-coenzyme A reductase inhibitor, lovastatin, to rabbits.
    Kornbrust DJ; MacDonald JS; Peter CP; Duchai DM; Stubbs RJ; Germershausen JI; Alberts AW
    J Pharmacol Exp Ther; 1989 Feb; 248(2):498-505. PubMed ID: 2918466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
    McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
    Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMG CoA reductase inhibitor-induced myotoxicity: pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture.
    Flint OP; Masters BA; Gregg RE; Durham SK
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):99-110. PubMed ID: 9221829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke.
    Krams M; Lees KR; Hacke W; Grieve AP; Orgogozo JM; Ford GA;
    Stroke; 2003 Nov; 34(11):2543-8. PubMed ID: 14563972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withdrawal of statins increases event rates in patients with acute coronary syndromes.
    Heeschen C; Hamm CW; Laufs U; Snapinn S; Böhm M; White HD;
    Circulation; 2002 Mar; 105(12):1446-52. PubMed ID: 11914253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins in the treatment of acute ischemic stroke.
    Montecucco F; Quercioli A; Mirabelli-Badenier M; Viviani GL; Mach F
    Curr Pharm Biotechnol; 2012 Jan; 13(1):68-76. PubMed ID: 21470160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity.
    Aarons CB; Cohen PA; Gower A; Reed KL; Leeman SE; Stucchi AF; Becker JM
    Ann Surg; 2007 Feb; 245(2):176-84. PubMed ID: 17245169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.